▶ 調査レポート

ホルモン避妊薬の世界市場:動向・シェア・規模・予測

• 英文タイトル:Hormonal Contraceptive Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

IMARCが調査・発行した産業分析レポートです。ホルモン避妊薬の世界市場:動向・シェア・規模・予測 / Hormonal Contraceptive Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027 / MRC-IM30192資料のイメージです。• レポートコード:MRC-IM30192
• 出版社/出版日:IMARC / 2022年10月
• レポート形態:英文、PDF、145ページ
• 納品方法:Eメール
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥374,850 (USD2,499)▷ お問い合わせ
  Enterprisewide¥674,850 (USD4,499)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
IMARC社の調査レポートによると、世界のホルモン避妊薬市場規模は2021年に170億ドルに達しました。今後、2027年には222億ドルになり、2022年から2022年の間に年平均4.81%成長すると予測しています。本調査レポートでは、ホルモン避妊薬の世界市場について調査・分析を行い、序論、調査範囲・手法、エグゼクティブサマリー、イントロダクション、製品別(経口避妊薬、子宮内避妊器具(IUD)、避妊注射、膣リング、その他)分析、ホルモン別(プロゲスチン避妊薬、複合ホルモン避妊薬)分析、年齢別(15ー24歳、25-34歳、35ー44歳、44歳以上)分析、エンドユーザー別(病院&クリニック、ホームケア、ASC、その他)分析、地域別(北米、アジア、欧州、中南米、中東・アフリカ)分析、SWOT分析(強み・弱み・機会・脅威)、バリューチェーン分析、ファイブフォース分析、価格分析、競争状況などを掲載しています。なお、企業情報には、Afaxys Inc., Agile Therapeutics Inc., Allergan Inc. (AbbVie Inc.), Bayer AG, Cipla Limited, Johnson & Johnson, Merck & Co. Inc., Pfizer Inc., Piramal Group and Teva Pharmaceutical Industries Ltd.などが含まれています。
・序論
・調査範囲・手法
・エグゼクティブサマリー
・イントロダクション
・世界のホルモン避妊薬市場規模:製品別
- 経口避妊薬の市場規模
- 子宮内避妊器具(IUD)の市場規模
- 避妊注射の市場規模
- 膣リングの市場規模
- その他製品の市場規模
・世界のホルモン避妊薬市場規模:ホルモン別
- プロゲスチン避妊薬の市場規模
- 複合ホルモン避妊薬の市場規模
・世界のホルモン避妊薬市場規模:年齢別
- 15ー24歳における市場規模
- 25-34歳における市場規模
- 35ー44歳における市場規模
- 44歳以上における市場規模
・世界のホルモン避妊薬市場規模:エンドユーザー別
- 病院&クリニックにおける市場規模
- ホームケアにおける市場規模
- ASCにおける市場規模
- その他エンドユーザーにおける市場規模
・世界のホルモン避妊薬市場規模:地域別
- 北米のホルモン避妊薬市場規模
- アジアのホルモン避妊薬市場規模
- 欧州のホルモン避妊薬市場規模
- 中南米のホルモン避妊薬市場規模
- 中東・アフリカのホルモン避妊薬市場規模
・SWOT分析(強み・弱み・機会・脅威)
・バリューチェーン分析
・ファイブフォース分析
・価格分析
・競争状況

The global hormonal contraceptive market size reached US$ 17.0 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 22.2 Billion by 2027, exhibiting a growth rate (CAGR) of 4.81% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

Hormonal contraceptives are formulations of progestin or a combination of estrogen and progesterone hormones. They act on the endocrine system to prevent ovulation and fertilization. As a result, they are used for preventing unwanted pregnancies and are also known to relieve period pain and often result in lighter periods. Hormonal contraceptives are considered one of the most effective methods, which can be taken before and after vaginal intercourse. They include birth control pills, vaginal rings, contraceptive skin patches, and hormone-releasing contraceptive coils. Hormonal contraceptives also affect the womb lining, making it hard for the fertilized eggs to be implanted.

Hormonal Contraceptive Market Trends:
The global hormonal contraceptive market is primarily driven by the increasing awareness among the masses regarding family planning. This has facilitated the need to prevent unintended pregnancies, especially among young couples. Furthermore, a significant rise in health issues associated with teenage pregnancies is promoting the use of contraceptives as they are easily accessible. Governments of different countries are also adopting various initiatives to support and improve access to these products by promoting affordable and high-quality healthcare services. Besides this, the advancements in the healthcare industry have resulted in the production of innovative products such as hormonal patches, implants, intrauterine devices, and drug-device combination products. These devices have fewer side effects and enhanced levels of efficiency in preventing pregnancy, which is favorably influencing the growth of the market.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global hormonal contraceptive market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on product, hormone, age group and end user.

Breakup by Product:

Oral Contraceptive Pills
Intrauterine Device (IUD)
Injectable Birth Control
Vaginal Rings
Others

Breakup by Hormone:

Progestin-only Contraceptive
Combined Hormonal Contraceptive

Breakup by Age Group:

15-24 Years
25-34 Years
35-44 Years
Above 44 Years

Breakup by End User:

Hospitals and Clinics
Homecare
Ambulatory Surgical Centers
Others

Breakup by Region:

North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Afaxys Inc., Agile Therapeutics Inc., Allergan Inc. (AbbVie Inc.), Bayer AG, Cipla Limited, Johnson & Johnson, Merck & Co. Inc., Pfizer Inc., Piramal Group and Teva Pharmaceutical Industries Ltd.

Key Questions Answered in This Report:
How has the global hormonal contraceptive market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global hormonal contraceptive market?
What are the key regional markets?
What is the breakup of the market based on the product?
What is the breakup of the market based on the hormone?
What is the breakup of the market based on the age group?
What is the breakup of the market based on the end user?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global hormonal contraceptive market and who are the key players?
What is the degree of competition in the industry?

レポート目次

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Hormonal Contraceptive Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Product
6.1 Oral Contraceptive Pills
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Intrauterine Device (IUD)
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Injectable Birth Control
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Vaginal Rings
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Others
6.5.1 Market Trends
6.5.2 Market Forecast
7 Market Breakup by Hormone
7.1 Progestin-only Contraceptive
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Combined Hormonal Contraceptive
7.2.1 Market Trends
7.2.2 Market Forecast
8 Market Breakup by Age Group
8.1 15-24 Years
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 25-34 Years
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 35-44 Years
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Above 44 Years
8.4.1 Market Trends
8.4.2 Market Forecast
9 Market Breakup by End User
9.1 Hospitals and Clinics
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Homecare
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Ambulatory Surgical Centers
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Others
9.4.1 Market Trends
9.4.2 Market Forecast
10 Market Breakup by Region
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia-Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 SWOT Analysis
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Afaxys Inc.
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.2 Agile Therapeutics Inc.
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.3 Allergan Inc. (AbbVie Inc.)
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.4 Bayer AG
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.4.3 Financials
15.3.4.4 SWOT Analysis
15.3.5 Cipla Limited
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.5.3 Financials
15.3.5.4 SWOT Analysis
15.3.6 Johnson & Johnson
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.6.3 Financials
15.3.6.4 SWOT Analysis
15.3.7 Merck & Co. Inc.
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.7.3 Financials
15.3.7.4 SWOT Analysis
15.3.8 Pfizer Inc.
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.8.3 Financials
15.3.8.4 SWOT Analysis
15.3.9 Piramal Group
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.9.3 Financials
15.3.10 Teva Pharmaceutical Industries Ltd
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.10.3 Financials
15.3.10.4 SWOT Analysis

Figure 1: Global: Hormonal Contraceptive Market: Major Drivers and Challenges
Figure 2: Global: Hormonal Contraceptive Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Hormonal Contraceptive Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 4: Global: Hormonal Contraceptive Market: Breakup by Product (in %), 2021
Figure 5: Global: Hormonal Contraceptive Market: Breakup by Hormone (in %), 2021
Figure 6: Global: Hormonal Contraceptive Market: Breakup by Age Group (in %), 2021
Figure 7: Global: Hormonal Contraceptive Market: Breakup by End User (in %), 2021
Figure 8: Global: Hormonal Contraceptive Market: Breakup by Region (in %), 2021
Figure 9: Global: Hormonal Contraceptive (Oral Contraceptive Pills) Market: Sales Value (in Million US$), 2016 & 2021
Figure 10: Global: Hormonal Contraceptive (Oral Contraceptive Pills) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 11: Global: Hormonal Contraceptive (Intrauterine Device-IUD) Market: Sales Value (in Million US$), 2016 & 2021
Figure 12: Global: Hormonal Contraceptive (Intrauterine Device-IUD) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 13: Global: Hormonal Contraceptive (Injectable Birth Control) Market: Sales Value (in Million US$), 2016 & 2021
Figure 14: Global: Hormonal Contraceptive (Injectable Birth Control) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 15: Global: Hormonal Contraceptive (Vaginal Rings) Market: Sales Value (in Million US$), 2016 & 2021
Figure 16: Global: Hormonal Contraceptive (Vaginal Rings) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 17: Global: Hormonal Contraceptive (Other Products) Market: Sales Value (in Million US$), 2016 & 2021
Figure 18: Global: Hormonal Contraceptive (Other Products) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 19: Global: Hormonal Contraceptive (Progestin-only Contraceptive) Market: Sales Value (in Million US$), 2016 & 2021
Figure 20: Global: Hormonal Contraceptive (Progestin-only Contraceptive) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 21: Global: Hormonal Contraceptive (Combined Hormonal Contraceptive) Market: Sales Value (in Million US$), 2016 & 2021
Figure 22: Global: Hormonal Contraceptive (Combined Hormonal Contraceptive) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 23: Global: Hormonal Contraceptive (15-24 Years) Market: Sales Value (in Million US$), 2016 & 2021
Figure 24: Global: Hormonal Contraceptive (15-24 Years) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 25: Global: Hormonal Contraceptive (25-34 Years) Market: Sales Value (in Million US$), 2016 & 2021
Figure 26: Global: Hormonal Contraceptive (25-34 Years) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 27: Global: Hormonal Contraceptive (35-44 Years) Market: Sales Value (in Million US$), 2016 & 2021
Figure 28: Global: Hormonal Contraceptive (35-44 Years) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 29: Global: Hormonal Contraceptive (Above 44 Years) Market: Sales Value (in Million US$), 2016 & 2021
Figure 30: Global: Hormonal Contraceptive (Above 44 Years) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 31: Global: Hormonal Contraceptive (Hospitals and Clinics) Market: Sales Value (in Million US$), 2016 & 2021
Figure 32: Global: Hormonal Contraceptive (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 33: Global: Hormonal Contraceptive (Homecare) Market: Sales Value (in Million US$), 2016 & 2021
Figure 34: Global: Hormonal Contraceptive (Homecare) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 35: Global: Hormonal Contraceptive (Ambulatory Surgical Centers) Market: Sales Value (in Million US$), 2016 & 2021
Figure 36: Global: Hormonal Contraceptive (Ambulatory Surgical Centers) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 37: Global: Hormonal Contraceptive (Other End Users) Market: Sales Value (in Million US$), 2016 & 2021
Figure 38: Global: Hormonal Contraceptive (Other End Users) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 39: North America: Hormonal Contraceptive Market: Sales Value (in Million US$), 2016 & 2021
Figure 40: North America: Hormonal Contraceptive Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 41: United States: Hormonal Contraceptive Market: Sales Value (in Million US$), 2016 & 2021
Figure 42: United States: Hormonal Contraceptive Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 43: Canada: Hormonal Contraceptive Market: Sales Value (in Million US$), 2016 & 2021
Figure 44: Canada: Hormonal Contraceptive Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 45: Asia-Pacific: Hormonal Contraceptive Market: Sales Value (in Million US$), 2016 & 2021
Figure 46: Asia-Pacific: Hormonal Contraceptive Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 47: China: Hormonal Contraceptive Market: Sales Value (in Million US$), 2016 & 2021
Figure 48: China: Hormonal Contraceptive Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 49: Japan: Hormonal Contraceptive Market: Sales Value (in Million US$), 2016 & 2021
Figure 50: Japan: Hormonal Contraceptive Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 51: India: Hormonal Contraceptive Market: Sales Value (in Million US$), 2016 & 2021
Figure 52: India: Hormonal Contraceptive Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 53: South Korea: Hormonal Contraceptive Market: Sales Value (in Million US$), 2016 & 2021
Figure 54: South Korea: Hormonal Contraceptive Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 55: Australia: Hormonal Contraceptive Market: Sales Value (in Million US$), 2016 & 2021
Figure 56: Australia: Hormonal Contraceptive Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 57: Indonesia: Hormonal Contraceptive Market: Sales Value (in Million US$), 2016 & 2021
Figure 58: Indonesia: Hormonal Contraceptive Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 59: Others: Hormonal Contraceptive Market: Sales Value (in Million US$), 2016 & 2021
Figure 60: Others: Hormonal Contraceptive Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 61: Europe: Hormonal Contraceptive Market: Sales Value (in Million US$), 2016 & 2021
Figure 62: Europe: Hormonal Contraceptive Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 63: Germany: Hormonal Contraceptive Market: Sales Value (in Million US$), 2016 & 2021
Figure 64: Germany: Hormonal Contraceptive Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 65: France: Hormonal Contraceptive Market: Sales Value (in Million US$), 2016 & 2021
Figure 66: France: Hormonal Contraceptive Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 67: United Kingdom: Hormonal Contraceptive Market: Sales Value (in Million US$), 2016 & 2021
Figure 68: United Kingdom: Hormonal Contraceptive Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 69: Italy: Hormonal Contraceptive Market: Sales Value (in Million US$), 2016 & 2021
Figure 70: Italy: Hormonal Contraceptive Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 71: Spain: Hormonal Contraceptive Market: Sales Value (in Million US$), 2016 & 2021
Figure 72: Spain: Hormonal Contraceptive Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 73: Russia: Hormonal Contraceptive Market: Sales Value (in Million US$), 2016 & 2021
Figure 74: Russia: Hormonal Contraceptive Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 75: Others: Hormonal Contraceptive Market: Sales Value (in Million US$), 2016 & 2021
Figure 76: Others: Hormonal Contraceptive Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 77: Latin America: Hormonal Contraceptive Market: Sales Value (in Million US$), 2016 & 2021
Figure 78: Latin America: Hormonal Contraceptive Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 79: Brazil: Hormonal Contraceptive Market: Sales Value (in Million US$), 2016 & 2021
Figure 80: Brazil: Hormonal Contraceptive Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 81: Mexico: Hormonal Contraceptive Market: Sales Value (in Million US$), 2016 & 2021
Figure 82: Mexico: Hormonal Contraceptive Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 83: Others: Hormonal Contraceptive Market: Sales Value (in Million US$), 2016 & 2021
Figure 84: Others: Hormonal Contraceptive Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 85: Middle East and Africa: Hormonal Contraceptive Market: Sales Value (in Million US$), 2016 & 2021
Figure 86: Middle East and Africa: Hormonal Contraceptive Market: Breakup by Country (in %), 2021
Figure 87: Middle East and Africa: Hormonal Contraceptive Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 88: Global: Hormonal Contraceptive Industry: SWOT Analysis
Figure 89: Global: Hormonal Contraceptive Industry: Value Chain Analysis
Figure 90: Global: Hormonal Contraceptive Industry: Porter's Five Forces Analysis